RUNX1 and acute myeloid leukemia: WGS of eight MDS and subsequent secondary-AML patient genomes. Targeted sequencing of 94 MDS/AML candidate loci. Each clone contained at least one mutation that recurs in MDS/AML. STAG2 mutations significantly co-occurred with RUNX1 mutations.